📰 Psilera Third Eye News
Psilera Third Eye News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Psilera Third Eye. Real-time updates on events, politics, business and more.
August 16, 2023
Cybin’s New US Patent Covers Proprietary Deuterated Psychedelic Analogs
March 30, 2023
/PRNewswire/ -- Psilera is proud to achieve a landmark preclinical milestone with 100% success. Its first cohort of drug candidates designed and synthesized...
December 8, 2022
/PRNewswire/ -- Psilera is proud to be an invited presenter at the Biotech Showcase of 2023 in San Francisco, CA. This prestigious event surrounding the JP...
October 20, 2022
/PRNewswire/ -- The 5th Annual Neuropsychiatric and Psychedelics Drug Development Summit will be held in Boston, MA from October 31st to November 2nd. Dr....
September 14, 2022
/PRNewswire/ -- Psilera Inc. ("Psilera"), a biopharmaceutical company optimizing next-generation mental health treatments, announces the patent approval of...